{"Ticker": "PFE", "Company": "Pfizer", "Sector": "Health Care", "Updated": "2022-12-13", "Rating": [{"Date": "2022-12-13", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$47 to $60"}, {"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$55"}, {"Date": "2022-05-23", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform", "Target_Change": "$55"}, {"Date": "2022-04-06", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$55"}, {"Date": "2022-01-05", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$59 to $70"}, {"Date": "2022-01-03", "Rating": "Reiterated", "Organization": "Bernstein", "Rating_Change": "Mkt Perform", "Target_Change": "$44 to $65"}, {"Date": "2021-12-20", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$56 to $70"}, {"Date": "2021-12-17", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$51"}, {"Date": "2021-12-13", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$52 to $60"}, {"Date": "2021-12-09", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$60"}, {"Date": "2021-11-19", "Rating": "Initiated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$60"}, {"Date": "2021-07-27", "Rating": "Resumed", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$43"}, {"Date": "2021-05-06", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$42"}, {"Date": "2021-04-07", "Rating": "Resumed", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$42"}, {"Date": "2021-02-04", "Rating": "Upgrade", "Organization": "DZ Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$41"}, {"Date": "2020-12-16", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$43 to $42"}, {"Date": "2020-11-19", "Rating": "Resumed", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$40"}, {"Date": "2020-11-10", "Rating": "Resumed", "Organization": "Bernstein", "Rating_Change": "Mkt Perform", "Target_Change": "$42"}, {"Date": "2020-10-12", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$44 to $39"}, {"Date": "2020-09-29", "Rating": "Initiated", "Organization": "Berenberg", "Rating_Change": "Hold", "Target_Change": "$38"}, {"Date": "2020-06-16", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform", "Target_Change": "$40"}, {"Date": "2020-02-27", "Rating": "Upgrade", "Organization": "Standpoint Research", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2020-02-27", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$36"}, {"Date": "2020-02-06", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2020-01-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$46"}, {"Date": "2019-10-17", "Rating": "Resumed", "Organization": "BofA/Merrill", "Rating_Change": "Neutral", "Target_Change": "$37"}]}